Kohanski, Michael A. http://orcid.org/0000-0001-8399-364X
Brown, Lauren
Orr, Melissa
Tan, Li Hui
Adappa, Nithin D.
Palmer, James N.
Rubenstein, Ronald C.
Cohen, Noam A.
Funding for this research was provided by:
American Rhinologic Society (Friends in Research Grant)
U.S. Department of Veterans Affairs (CX001617)
National Institutes of Health (R01 HL135670)
Article History
Received: 21 October 2020
Accepted: 20 January 2021
First Online: 28 January 2021
Ethics approval and consent to participate
: Informed consent to use residual tissue was obtained from patients recruited from the Department of Otorhinolaryngology – Head and Neck Surgery, Division of Rhinology, University of Pennsylvania with Institutional Review Board approval (protocol # 800614).
: Not applicable.
: MAK, LHT, NDA, J.NP and NAC have a patent pending for Quinine and its use to generate innate immune response licensed to GeneOne Lifesciences Inc. RRC reports contributing as an investigator for Vertex Pharmaceuticals, Celtaxsys and Proteostasis; grants and personal fees from Cystic Fibrosis Foundation, personal fees from Guidepoint Global, Gerson Lehrman Group and from pH Pharma outside the submitted work. LB and MO report no conflicts of interest.